PT Merck Tbk stock analysis
PT Merck Tbk (MERK) Stock Price & Analysis
MERK Stock Chart & Stats
- Day’s Range
- IDR 3,430.00 - IDR 3,490.00
- 52-Week Range
- IDR 2,820.00 - IDR 4,500.00
- Previous Close
- IDR 3,490.00
- Volume
- N/A
- Average Volume (3M)
- 15.35K
- Market Cap
- IDR 1.56T
- Enterprise Value
- IDR 1.16T
- Total Cash (Recent Filing)
- IDR 368.74B
- Total Debt (Recent Filing)
- IDR 17.46B
- Price to Earnings (P/E)
- 6.5
- Beta
- 0.32
- Next Earnings
- Apr 15, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 08, 2026
- Dividend Yield
- 7.97%
MERK FAQ
What was PT Merck Tbk’s price range in the past 12 months?
What is PT Merck Tbk’s market cap?
When is PT Merck Tbk’s upcoming earnings report date?
How were PT Merck Tbk’s earnings last quarter?
Is PT Merck Tbk overvalued?
Does PT Merck Tbk pay dividends?
What is PT Merck Tbk’s EPS estimate?
How many shares outstanding does PT Merck Tbk have?
What happened to PT Merck Tbk’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PT Merck Tbk?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PT Merck Tbk
Operating in Indonesia, PT Merck Tbk is a pharmaceutical company focused on the production and distribution of medicinal products. Its business operations are structured into three main divisions: Biopharma, Consumer Health, and an 'Others' segment. The company provides healthcare solutions addressing a broad spectrum of therapeutic areas, including conditions related to the cardiovascular system, metabolism, oncology, endocrinology, fertility, and neurodegenerative disorders, alongside general pharmaceutical offerings. Furthermore, PT Merck Tbk is actively involved in the discovery, development, production, and commercialization of both pharmaceutical and biological prescription drugs. These medicines target specific conditions such as colorectal and head and neck cancers, multiple sclerosis, infertility, growth hormone imbalances, diabetes, and various thyroid conditions like hyperthyroidism and hypothyroidism. Beyond its core pharmaceutical activities, the company also engages in property leasing and management. Established in 1970 and headquartered in East Jakarta, Indonesia, the company was originally known as PT Merck Indonesia Tbk before adopting its current name, PT Merck Tbk, in June 2002. It operates as a subsidiary of Merck Holding GmbH.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Evie Yulin
- Employees
- 331
- Website
- www.merckgroup.com/id-id
- Address
- Jl. TB Simatupang No. 8, Jakarta Timur, JK, 13760, ID
PT Merck Tbk (MERK) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 6 | 14 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 0 | 0 | 12 |

